| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/28/2005 | WO2005068087A2 Method for coating an object with hydrophobin at low temperatures |
| 07/28/2005 | WO2005025516A3 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 07/28/2005 | WO2004058946A3 Protein arrays |
| 07/28/2005 | WO2003089900A3 Protein arrays and methods of production |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050164249 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography |
| 07/27/2005 | EP1557429A1 Site-directed coupling of proteins |
| 07/27/2005 | EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 07/27/2005 | EP1556065A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/21/2005 | WO2005030979A3 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays |
| 07/21/2005 | WO2005011607A3 Treatment of cancers expressing p95 erbb2 |
| 07/21/2005 | US20050158782 Magnetic fine particles having lower critical solution temperature |
| 07/21/2005 | US20050158780 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/21/2005 | US20050158743 Arrays for detecting nucleic acids |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | EP1553971A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-b |
| 07/19/2005 | US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis |
| 07/19/2005 | US6919076 Conjugate of a nonextracellular matrix protein, nonlabeling agent of an anti- nerve gas, neurotoxin and gluacoma agents and a carboxamide- carrying linking molecule that contains >/= 2 linked glutamines and is a substrate of transglutaminase |
| 07/14/2005 | WO2005064336A1 Pyrenyloxysulfonic acid fluorescent agents |
| 07/14/2005 | WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153363 Polymer arrays |
| 07/14/2005 | US20050153362 Polymer arrays |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/13/2005 | EP1552305A2 Polypeptide immobilization |
| 07/13/2005 | EP1552304A2 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/09/2005 | CA2452162A1 Diabetogenic epitope from a .alpha./.beta.-gliadin a-ii precursor, .alpha./.beta.-gliadin mm1 precursor or g1b1 |
| 07/07/2005 | WO2005061482A1 Ecstasy haptens and immunogens |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | CN1634993A Recombined human interferon-alpha 1b compound and process for preparation |
| 07/05/2005 | CA2118928C Saponin-antigen conjugates and the use thereof |
| 06/30/2005 | WO2005059100A2 Methods and compositions relating to cystatin c |
| 06/30/2005 | WO2005058948A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/30/2005 | WO2005058865A2 Assay for entactogens |
| 06/30/2005 | WO2005058864A1 Assay for entactogens |
| 06/30/2005 | CA2548792A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/29/2005 | EP1547451A2 Cell adhesion resisting surfaces |
| 06/29/2005 | EP1546235A2 Water-soluble polymer alkanals |
| 06/29/2005 | EP1545576A2 Methods of using non-human animal apoliprotein a-i protein |
| 06/29/2005 | EP0954326B1 A process for viral inactivation of lyophilized blood proteins |
| 06/29/2005 | CN1632116A Enhancement of virus-mediated DNA transfer |
| 06/23/2005 | WO2005057462A1 A method for designing surfaces |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005056569A2 Beta integrin gene and protein |
| 06/23/2005 | WO2005055957A2 Influenza immunogen and vaccine |
| 06/23/2005 | WO2004018997A3 Methods and compositions for modulating amyloid beta |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | CA2552435A1 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 06/23/2005 | CA2549104A1 Influenza immunogen and vaccine |
| 06/22/2005 | EP1544211A1 LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/22/2005 | EP1543166A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/22/2005 | EP1543037A2 Dendritic cell pontentiation |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | CN1629193A Protein and polypeptide guanidine polyethyleneglycol reagent and its preparation process and use |
| 06/21/2005 | US6908985 Heat-shock protein- binding proteins; useful in the regulation of physiological events in which one or more 70 kiloDalton heat-shock proteins (Hsp70) are involved, such as normal development, cellular stress responses, heart disease |
| 06/16/2005 | WO2005053617A2 Compositions and methods comprising collagen |
| 06/16/2005 | WO2003018854A3 Immobilization of biological molecules onto surfaces coated with monolayers |
| 06/16/2005 | US20050131219 Methods for reducing complexity of a sample using small epitope antibodies |
| 06/16/2005 | US20050130244 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050130225 Ecstasy haptens and immunogens |
| 06/15/2005 | EP1540345A2 Microarrays on mirrored substrates for performing proteomic analyses |
| 06/15/2005 | EP1539793A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 06/15/2005 | EP1539342A2 Peptide mediated synthesis of metallic and magnetic materials |
| 06/15/2005 | CN1627070A Method for preparing water-soluble cross-linked conjugates |
| 06/15/2005 | CN1626549A Carbowax alcoholized ramification of TimopEntin, combination of medication and application |
| 06/09/2005 | WO2005051976A2 Protein and peptide ligation processes and one-step purification processes |
| 06/09/2005 | US20050123935 For use in multicolor/multiplexing assays; bioconjugation; kits |
| 06/09/2005 | CA2547435A1 Targeting of erb antigens |
| 06/08/2005 | EP1497469A4 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 06/08/2005 | EP0882463B1 Adsorbent for immunoglobulins and complexes thereof and adsorption device |
| 06/08/2005 | CN1625409A Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 06/08/2005 | CN1205228C Process for synthesizing chiral fixed phase of liquid-phase chromatographic protein |
| 06/07/2005 | US6903202 DNA encoding proteins that inhibit Hsp70 function |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease |
| 06/02/2005 | WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 06/02/2005 | US20050118706 Polymer arrays |
| 06/02/2005 | US20050118673 Applying an enzyme for the selective removal of sub-unit parts of the polymer to at least one predetermined area of said polymeric substrate via a pipette with a nano-sized orifice |
| 06/02/2005 | US20050118672 Using peptide: N-Glycosidase F (PNGase-F) to generate glycopeptide with uniform glycosylation patterns |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118619 Dark quenchers for fluorescence resonance energy transfer (FRET) in bioassays |
| 06/02/2005 | CA2486510A1 A process for creating a 3-dimensional configuration on a substrate |
| 06/01/2005 | EP1534755A1 Generation of surface coating diversity |
| 06/01/2005 | EP1534740A2 Composition and method for stabilising biomolecules |
| 06/01/2005 | EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 05/31/2005 | US6900047 Apparatus for coating a substrate quickly and uniformly with a small volume of fluid |
| 05/31/2005 | US6899889 Biocompatible material composition adaptable to diverse therapeutic indications |
| 05/26/2005 | WO2005046587A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |